- Home
- RMBI vs INMB Comparison
RMBI vs INMB Comparison
Compare RMBI & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBI
- INMB
- Stock Information
- Founded
- RMBI 1887
- INMB 2015
- Country
- RMBI United States
- INMB United States
- Employees
- RMBI N/A
- INMB N/A
- Industry
- RMBI Major Banks
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- RMBI Finance
- INMB Health Care
- Exchange
- RMBI Nasdaq
- INMB Nasdaq
- Market Cap
- RMBI 148.9M
- INMB 176.5M
- IPO Year
- RMBI 2019
- INMB 2019
- Fundamental
- Price
- RMBI $14.25
- INMB $8.06
- Analyst Decision
- RMBI
- INMB Strong Buy
- Analyst Count
- RMBI 0
- INMB 3
- Target Price
- RMBI N/A
- INMB $24.33
- AVG Volume (30 Days)
- RMBI 37.4K
- INMB 223.6K
- Earning Date
- RMBI 04-24-2025
- INMB 05-08-2025
- Dividend Yield
- RMBI 4.27%
- INMB N/A
- EPS Growth
- RMBI 2.54
- INMB N/A
- EPS
- RMBI 0.89
- INMB N/A
- Revenue
- RMBI $42,825,048.00
- INMB $50,000.00
- Revenue This Year
- RMBI N/A
- INMB N/A
- Revenue Next Year
- RMBI N/A
- INMB N/A
- P/E Ratio
- RMBI $15.88
- INMB N/A
- Revenue Growth
- RMBI 2.64
- INMB N/A
- 52 Week Low
- RMBI $10.88
- INMB $4.32
- 52 Week High
- RMBI $15.15
- INMB $11.76
- Technical
- Relative Strength Index (RSI)
- RMBI 62.70
- INMB 56.55
- Support Level
- RMBI $13.60
- INMB $6.85
- Resistance Level
- RMBI $14.30
- INMB $7.77
- Average True Range (ATR)
- RMBI 0.46
- INMB 0.46
- MACD
- RMBI 0.01
- INMB 0.02
- Stochastic Oscillator
- RMBI 94.44
- INMB 86.43
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.